Description
IBUPROFEN TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM MOD #1 DECREASES FUNDING FOR 1 REJECTED BOX OF IBUPROFEN 800MG TABLETS
Base award description: IBUPROFEN TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM (797-D-9657)
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-05-21+$236,417= $236,417
- Mod P000012013-06-20-$219= $236,198
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-05-21 | +$236,417 | $236,417 | IBUPROFEN TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM (797-D-9657) |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2013-06-20 | −$219 | $236,198 | IBUPROFEN TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM MOD #1 DECREASES FUNDING FOR 1 REJECTED BOX OF IBUPRO… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LVEBAQTPN615)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0013 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026F0059 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $319,399 | FY2026 |
| 36C26025F0044 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $173,089 | FY2025 |
| 36C26024F0050 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $185,400 | FY2024 |
| 36E79724A0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36F79722D0161 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
Other recipients under 6505 from DEPT OF VETERANS AFFAIRS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P16J0052 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $71,957 | FY2016 |
| VA797P16J0053 | EXCELLIUM PHARMACEUTICAL INC. | DEPT OF VETERANS AFFAIRS | $69,294 | FY2016 |
| VA797P16J0050 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $22,663 | FY2016 |
| VA797P16J0049 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $32,995 | FY2016 |
| VA797P16J0048 | SANDOZ INC. | DEPT OF VETERANS AFFAIRS | $26,142 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA797P13J0051_3600_VA797P12A0006_3600 · retrieved 2026-09-26.